Brian Tanquilut analyst JEFFERIES

Currently out of the existing stock ratings of Brian Tanquilut, 210 are a BUY (76.36%), 63 are a HOLD (22.91%), 2 are a SELL (0.73%).

Brian Tanquilut

Work Performance Price Targets & Ratings Chart

Analyst Brian Tanquilut, currently employed at JEFFERIES, carries an average stock price target met ratio of 60% that have a potential upside of 19.22% achieved within 303 days.

Brian Tanquilut’s has documented 546 price targets and ratings displayed on 47 stocks. The coverage is on Healthcare, Consumer Cyclical sectors.

Most recent stock forecast was given on MD, Mednax at 19-Aug-2026.

Wall Street Analyst Brian Tanquilut

Analyst best performing recommendations are on HCSG (HEALTHCARE SERVICES GROUP).
The best stock recommendation documented was for WBA (WALGREENS BOOTS ALLIANCE) at 3/29/2024. The price target of $19 was fulfilled within 3 days with a profit of $1.28 (6.31%) receiving and performance score of 21.04.

Average potential price target upside

ABC AmerisourceBergen ACHC Acadia Healthcare Company ADUS Addus HomeCare AHCO Adapthealth Corp AMED Amedisys BKD Brookdale Senior Living CMAX CareMax CVS CVS Health Corp CYH Community Health Systems DGX Quest Diagnostics EHC Encompass Health Corp EVHC Envision Healthcare Holdings LH Laboratory of America Holdings LHCG LHC Group RDNT RadNet SGRY Surgery Partners THC Tenet Healthcare TMH Team Health Holdings USPH US Physicalrapy WBA Walgreens Boots Alliance HCA HCA Holdings MCK McKesson MD Mednax AGL agilon health CAH Cardinal Health CANO Cano Health OSH Oak Street Health PRVA Privia Health Group AVAH Aveanna Healthcare Holdings HNGR Hanger MODV ModivCare AMN AMN Healthcare Services HCSG Healthcare Services Group EHAB Enhabit CCRN Cross Country Healthcare OPCH Option Care Health EYE National Vision Holdings CHE Chemed Corp WOOF Pet Acquisition LLC ADPT Adaptive Biotechnologies Corp AGTI Agiliti BTSG BrightSpring Health Services, Common Stock COR Cencora LFST Lifestance Health Group ODD ODDITY Tech Ltd. Ordinary Shares PNTG Pennant Group TOI Oncology Institute

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 27-Feb-2018

$215

$40.04 (22.89%)

$187

3 years 1 months 7 days ago
(07-Aug-2023)

15/16 (93.75%)

$28.91 (15.54%)

636

Hold Since 27-May-2022

$190

$15.04 (8.60%)

$176

3 years 1 months 11 days ago
(03-Aug-2023)

12/12 (100%)

$-0.86 (-0.45%)

392

Buy Since 11-Oct-2022

$215

$40.04 (22.89%)

$200

3 years 1 months 11 days ago
(03-Aug-2023)

7/10 (70%)

$24.14 (12.65%)

211

Buy Since 05-Aug-2021

$220

$45.04 (25.74%)

$213

3 years 1 months 11 days ago
(03-Aug-2023)

11/17 (64.71%)

$29.14 (15.27%)

326

$190

$15.04 (8.60%)

3 years 1 months 11 days ago
(03-Aug-2023)

9/9 (100%)

$-0.86 (-0.45%)

440

Show more analysts

Please expand the browser size to see the chart

Which stock is Brian Tanquilut most bullish on?

Potential upside of $1.64 has been obtained for ACHC (ACADIA HEALTHCARE COMPANY)

Which stock is Brian Tanquilut most reserved on?

Potential downside of $1.23 has been obtained for MD (MEDNAX)

What Year was the first public recommendation made by Brian Tanquilut?

On 2008

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?